Physician profile
Bridget Mashburn
NPI 1982210928
$1,875.12
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $434 · 2022: $636 · 2023: $344 · 2024: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.29 | 2021-2024 | |
| Glaxosmithkline, LLC. | $242.39 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $194.62 | 2021-2024 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.19 | 2021-2024 | Synjardy, Jardiance, Tradjenta |
| Scynexis, INC. | $93.82 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $80.55 | 2021-2024 | Breztri |
| Novartis Pharmaceuticals Corporation | $76.26 | 2021-2022 | |
| Novo Nordisk INC | $64.46 | 2021-2024 | Rybelsus, Ozempic |
| Amgen INC. | $56.10 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $51.86 | 2022 | |
| Exact Sciences Corporation | $45.04 | 2023-2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $44.17 | 2021-2024 | Rexulti |
| Esperion Therapeutics, INC. | $39.38 | 2021 | |
| Pfizer INC. | $38.17 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $33.99 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $33.60 | 2022 | |
| Vanda Pharmaceuticals INC. | $28.88 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $27.62 | 2024 | |
| Alnylam Pharmaceuticals INC. | $21.78 | 2024 | Givlaari |
| Dexcom, INC. | $21.34 | 2024 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $14.62 | 2021 | |
| Nestle Healthcare Nutrition INC. | $13.82 | 2021 | |
| Grt US Holding, INC. | $12.13 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.32 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.72 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Mashburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.